Evidence map›Paper›PMID 33054774›Full record

ArticleBMC psychiatry2020

Study protocol of comprehensive risk evaluation for anorexia nervosa in twins (CREAT): a study of discordant monozygotic twins with anorexia nervosa.

Maria Seidel, Stefan Ehrlich, Lauren Breithaupt, Elisabeth Welch, Camilla Wiklund, Christopher Hübel, Laura M Thornton, Androula Savva, Bengt T Fundin, Jessica Pege and 13 more

Open access · goldAbstract readTwin Study
In one paragraph

Article in BMC psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 5 countries.

Maria SeidelDivision of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.
Stefan EhrlichDivision of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany. stefan.ehrlich@uniklinikum-dresden.de.
Lauren BreithauptDepartment of Psychiatry, Harvard Medical School, Boston, MA, USA.
Elisabeth WelchCentre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Camilla WiklundDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutetet, Nobels väg 12A, 17165, Stockholm, Solna, Sweden.
Christopher HübelDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutetet, Nobels väg 12A, 17165, Stockholm, Solna, Sweden.
Laura M ThorntonDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Androula SavvaDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutetet, Nobels väg 12A, 17165, Stockholm, Solna, Sweden.
Bengt T FundinDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutetet, Nobels väg 12A, 17165, Stockholm, Solna, Sweden.
Jessica PegeDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutetet, Nobels väg 12A, 17165, Stockholm, Solna, Sweden.
Annelie BillgerDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutetet, Nobels väg 12A, 17165, Stockholm, Solna, Sweden.
Afrouz AbbaspourDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutetet, Nobels väg 12A, 17165, Stockholm, Solna, Sweden.
Martin SchaeferDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Ilka BoehmDivision of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.
Johan ZvrskovecDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutetet, Nobels väg 12A, 17165, Stockholm, Solna, Sweden.
Emilie Vangsgaard RosagerDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Katharina Collin HasselbalchDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Virpi LeppäDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutetet, Nobels väg 12A, 17165, Stockholm, Solna, Sweden.
Magnus SjögrenDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Ricard NergårdhDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Jamie D FeusnerDepartment of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, USA.
Ata GhaderiSocial, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Cynthia M BulikDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutetet, Nobels väg 12A, 17165, Stockholm, Solna, Sweden. cynthia.bulik@ki.se.
Karolinska Institutet · SETU Dresden · DEUniversity of Copenhagen · DKCenter for Clinical & Basic Research · DKMassachusetts General Hospital · USUniversity of California, Los Angeles · USUniversity of North Carolina at Chapel Hill · US

Funding

Vetenskapsrådet 538-2013-8864
6 · The paper itself

Abstract

backgroundAnorexia nervosa (AN) is a severe disorder, for which genetic evidence suggests psychiatric as well as metabolic origins. AN has high somatic and psychiatric comorbidities, broad impact on quality of life, and elevated mortality. Risk factor studies of AN have focused on differences between acutely ill and recovered individuals. Such comparisons often yield ambiguous conclusions, as alterations could reflect different effects depending on the comparison. Whereas differences found in acutely ill patients could reflect state effects that are due to acute starvation or acute disease-specific factors, they could also reflect underlying traits. Observations in recovered individuals could reflect either an underlying trait or a "scar" due to lasting effects of sustained undernutrition and illness. The co-twin control design (i.e., monozygotic [MZ] twins who are discordant for AN and MZ concordant control twin pairs) affords at least partial disambiguation of these effects.

methodsComprehensive Risk Evaluation for Anorexia nervosa in Twins (CREAT) will be the largest and most comprehensive investigation of twins who are discordant for AN to date. CREAT utilizes a co-twin control design that includes endocrinological, neurocognitive, neuroimaging, genomic, and multi-omic approaches coupled with an experimental component that explores the impact of an overnight fast on most measured parameters. DISCUSSION: The multimodal longitudinal twin assessment of the CREAT study will help to disambiguate state, trait, and "scar" effects, and thereby enable a deeper understanding of the contribution of genetics, epigenetics, cognitive functions, brain structure and function, metabolism, endocrinology, microbiology, and immunology to the etiology and maintenance of AN.

Indexed as

Anorexia NervosaTwins, MonozygoticDiseases in TwinsHumansQuality of LifeRisk FactorsAnorexia nervosaCognitive functionsGeneticsMetabolismMicrobiotaNeuroimagingRisk factorsStudy protocolTwin study

Identifiers

PMID33054774
PMCPMC7557028
OpenAlexW3093037295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.